Nanalysis Scientific (TSE:NSCI) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Nanalysis Scientific Corp. and the United States Pharmacopeia have co-published a study demonstrating the effectiveness of benchtop NMR technology for quality control in pharmaceuticals. The study highlights the advantages of this portable NMR solution, including faster measurements and reduced solvent usage, making it an accessible and scalable option for the industry. This advancement positions Nanalysis Scientific to potentially drive growth in pharmaceutical quality assurance globally.
For further insights into TSE:NSCI stock, check out TipRanks’ Stock Analysis page.